Synthesis, Characterization and Aggregation Behavior of Polyethylene Glycol-conjugated Hydroxycamptothecin

被引:1
|
作者
Qiu Chuanlong [1 ]
Li Chunfang [1 ]
Li Dongxiang [1 ]
Hou Wanguo [2 ]
机构
[1] Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, State Key Lab Base Ecochem Engn, Qingdao 266042, Peoples R China
[2] Shandong Univ, Minist Educ, Key Lab Colloid & Interface Chem, Jinan 250100, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Hydroxycamptothecin; Polyethylene glycol; Solubility; Lactone ring stability; LAYERED DOUBLE HYDROXIDE; POLY(ETHYLENE GLYCOL); MICELLAR-SOLUTIONS; CAMPTOTHECIN; 10-HYDROXYCAMPTOTHECIN; PHARMACOKINETICS; NANOMEDICINE; PHARMACOLOGY; NANOHYBRIDS; HYDROLYSIS;
D O I
10.7503/cjcu20150895
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Methoxypolyethylene glycol(MPEG)-conjugated hydroxycamptothecin(HCPT), denoted as MPEG-HCPT, was synthesized via etherification reaction between terminal hydroxyl of MPEG and 10-hydroxy of HCPT, and they were characterized via H-1 NMR and FTIR. The effect of MPEG conjugation on the solubility and lactone-ring stability of HCPT was investigated, as well as its aggregation behavior. The mass fraction of HCPT in the derivative was approximately 33% and the solubility of the MPEG-HCPT in buffer solutions of pH 4. 8 and 7. 2 at 37 degrees C were respectively 5. 23 and 7. 90 mmol/L, significantly higher than those of pristine HCPT (0. 0026 and 0. 035 mmol/L). The pK(ah)(K-ah, the apparent hydrolysis equilibrium constant) of MPEG-HCPT at 37 degrees C was determined to be approximately 7. 12, higher than that of pristine HCPT (ca. 6. 67), indicating that the MPEG conjugation could enhance the lactone-ring stability of HCPT. The MPEG-HCPT exhibited obvious surface activity, and could form aggregates in water with a aggregation micelle concentration of 0. 46 mmol/L.
引用
收藏
页码:1535 / 1541
页数:7
相关论文
共 32 条
  • [1] AKIMOTO K, 1994, CHEM PHARM BULL, V42, P2135, DOI 10.1248/cpb.42.2135
  • [2] Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
    Bala, Vaskor
    Rao, Shasha
    Boyd, Ben J.
    Prestidge, Clive A.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : 48 - 61
  • [3] Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers
    Barreiro-Iglesias, R
    Bromberg, L
    Temchenko, M
    Hatton, TA
    Concheiro, A
    Alvarez-Lorenzo, C
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 97 (03) : 537 - 549
  • [4] LIPID BILAYER PARTITIONING AND STABILITY OF CAMPTOTHECIN DRUGS
    BURKE, TG
    MISHRA, AK
    WANI, MC
    WALL, ME
    [J]. BIOCHEMISTRY, 1993, 32 (20) : 5352 - 5364
  • [5] Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy
    Chourpa, I
    Millot, JM
    Sockalingum, GD
    Riou, JF
    Manfait, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1998, 1379 (03): : 353 - 366
  • [6] Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion
    Cortesi, R
    Esposito, E
    Maietti, A
    Menegatti, E
    Nastruzzi, C
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 159 (01) : 95 - 103
  • [7] Synthesis and release behavior of composites of camptothecin and layered double hydroxide
    Dong, Lun
    Li, Yan
    Hou, Wan-Guo
    Liu, Shao-Jie
    [J]. JOURNAL OF SOLID STATE CHEMISTRY, 2010, 183 (08) : 1811 - 1816
  • [8] Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro
    EricksonMiller, CL
    May, RD
    Tomaszewski, J
    Osborn, B
    Murphy, MJ
    Page, JG
    Parchment, RE
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (05) : 467 - 472
  • [9] Garcia-Carbonero R, 2002, CLIN CANCER RES, V8, P641
  • [10] Modulation of camptothecin analogs in the treatment of cancer: a review
    Kehrer, DFS
    Soepenberg, O
    Loos, WJ
    Verweij, J
    Sparreboom, A
    [J]. ANTI-CANCER DRUGS, 2001, 12 (02) : 89 - 105